ACS Medicinal Chemistry Letters · 2010 · 119 citations · 14 references
Life SciencesBiochemistryPharmacologyDrug DeliveryNanobiotechnologyNanoparticle Drug DeliveryCell-nanoparticle InteractionsEnzyme InhibitionNanomaterials For Drug DeliveryNanomedicineProtozoan Host-parasite InteractionsProtozoan PathogenesisAntileishmanial TreatmentAntiproliferative AgentsAntiproliferative Drug ActionGlutathione Reductase SystemLeishmaniasis PathogenesisNanoparticlesTreatment Of LeishmaniasisTreatment Of Trypanosomiasis
In Leishmania the glutathione/glutathione reductase eukaryotic redox sys-tem is replaced by the unique trypanothione/trypanothione reductase (TR) system. In vitro, silver is a more effective TR inhibitor than antimony, the first line drug against leishmaniasis in most endemic countries, and its mechanism of inhibition is similar to that of Sb(III). In particular, silver binds with high affinity to the catalytic triad Cys52, Cys57, and His461', thereby inhibiting TR. Here, Ag(0) activity was tested on the promastigote and amastigote stages of Leishmania infantum using a drug-delivery system consisting in Ag(0) nanoparticles encapsulated by ferritin molecules (PfFt-AgNPs). These were able to induce an antiproliferative effect on the parasites at metal concentrations lower than those used with antimony.
14
The PyMOL Molecular Graphics System
Warren L. DeLano · Medical Entomology and Zoology · 2002 · 18.1K citations
Molecular Basis of Antimony Treatment in Leishmaniasis
Paola Baiocco, Gianni Colotti, S. Franceschini et al. · Journal of Medicinal Chemistry · 2009 · 285 citations